AXSM

Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York City, dedicated to developing innovative therapies for central nervous system (CNS) disorders. The company is focused on addressing significant unmet medical needs within this therapeutic area, boasting a robust pipeline of candidates targeting conditions such as depression, migraine, and chronic pain. With a strong commitment to enhancing patient outcomes and a solid scientific foundation, Axsome is strategically positioned to deliver transformative solutions in CNS medicine, making it a compelling prospect for institutional investors looking to capitalize on advancements in mental health treatment.